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The amino acid sequence of the cell-surface-exposed, 81-kDa CopB outer membrane protein of Moraxella
catarrhalis was found to be similar to those of TonB-dependent outer membrane proteins of other gram-
negative bacteria. Expression of CopB was affected by the availability of iron in the growth medium, and the
extent of overexpression of CopB in response to iron limitation varied widely among the M. catarrhalis strains
tested. Wild-type M. catarrhalis strains were found to be able to utilize ferric citrate, transferrin, lactoferrin,
and heme as sources of iron for growth in vitro. However, an isogenic copB mutant was severely impaired in
its ability to utilize transferrin and lactoferrin as sole sources of iron for growth, whereas this same mutant
grew similarly to the wild-type parent strain when supplied with ferric citrate as the iron source. The copB
mutant was not significantly different from its wild-type parent strain in its ability to bind transferrin and
lactoferrin. In addition, the wild-type parent strain and the copB mutant exhibited equivalent rates of uptake
of 55Fe from ferric citrate. However, the copB mutant was markedly less able than the wild-type strain to take
up 55Fe from transferrin and lactoferrin. These results indicate that lack of expression of the CopB protein
exerts a direct or indirect effect on the ability of M. catarrhalis to utilize iron bound to certain carrier proteins.
Moraxella (Branhamella) catarrhalis is a common respiratory
tract pathogen in humans. In children, this gram-negative or-
ganism is responsible for up to 20% of cases of acute otitis
media (3, 14, 18). In fact, in a recent report, M. catarrhalis
DNA could be detected by PCR in middle ear effusions from
46% of patients with chronic otitis media with effusion (40). In
adults, M. catarrhalis commonly causes lower respiratory tract
infections in patients with chronic obstructive lung disease (13,
20, 31). In immunocompromised hosts, and mainly in patients
with hematologic malignancies, M. catarrhalis has been identi-
fied as an etiologic agent of bacteremia, meningitis, skeletal
infections, endocarditis, and other invasive focal infections (13,
15, 20, 29, 31).
The recent recognition of M. catarrhalis as an important
pathogen in both the upper and lower respiratory tract has
resulted in increased interest in its interactions with the human
host and, more specifically, in its antigenic composition. Outer
membrane proteins constitute major antigenic determinants of
this unencapsulated organism (4), and different strains share
remarkably similar outer membrane protein profiles (4, 33).
CopB (outer membrane protein B2), a major and antigenically
well-conserved 81-kDa outer membrane protein of M. catar-
rhalis 035E, has been characterized in detail (23). Antibody to
this surface-exposed protein is bactericidal and has been shown
to enhance the rate of clearance of M. catarrhalis from the
lungs of mice (23). A copB mutation rendered M. catarrhalis
less able to resist pulmonary clearance in this mouse model
and also converted the serum-resistant wild-type strain to a
serum-sensitive phenotype (24).
Expression of CopB by M. catarrhalis strains growing in a
rich, undefined medium appeared to be constitutive in a pre-
vious study from this laboratory (23). However, a recent report
from Campagnari et al. (10) suggested that a number of M.
catarrhalis outer membrane proteins with apparent molecular
masses of 80 to 115 kDa, including what appeared to be CopB,
were expressed in greater abundance when the availability of
iron in the growth medium was limited. In the present study,
we show that there are strain-dependent differences in M.
catarrhalis involving the level of CopB expression in response
to iron limitation. Moreover, we have found that the amino
acid sequence of the CopB protein resembles that of TonB-
dependent outer membrane proteins, and especially that of
one particular iron-regulated protein from Neisseria gonor-
rhoeae (6) and Neisseria meningitidis (39). Finally, we have
found that an isogenic copB mutant is impaired in its ability to
utilize both transferrin and lactoferrin as sources of iron for
growth in vitro.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains used in this
study are listed in Table 1. The wild-type M. catarrhalis strain 035E and its
isogenic copB mutant 035E-CopB2 have been described in detail elsewhere (23,
24).M. catarrhalis 012E is a serum-resistant isolate derived from middle ear fluid
(23). A third wild-typeM. catarrhalis strain (ATCC 25240) was obtained from the
American Type Culture Collection, Rockville, Md. M. catarrhalis strains were
routinely cultured in brain heart infusion (BHI) broth (Difco Laboratories,
Detroit, Mich.) at 378C or on BHI agar plates in an atmosphere of 95% air–5%
CO2. BHI broth and agar plates were iron depleted by adding deferoxamine
mesylate (Desferal; Ciba-Geigy, Basel, Switzerland) to a final concentration of
30 mM (BHI-DF30) and incubating at 48C overnight before use. For 55Fe uptake
studies, bacterial cells were grown in chemically defined medium (CDM) as
described previously (46). N. gonorrhoeae strains (32) were routinely grown on
chocolate agar plates. Haemophilus influenzae type b strain DL42 was grown
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routinely by using BHI medium supplemented with Levinthal’s base (1). Esche-
richia coli HB101 was grown in Luria-Bertani medium (30) at 378C.
Iron sources. Human transferrin (30% iron saturated), human lactoferrin
(90% iron saturated), bovine hemin (heme), and human hemoglobin were ob-
tained from Sigma Chemical Co., St. Louis, Mo. Heme:hemopexin complexes
and hemoglobin:haptoglobin complexes were provided by Ursula Muller-Eber-
hard, Cornell Medical Center, New York, N.Y. Ferric citrate was prepared by
adding a 10-fold molar excess of sodium citrate to FeCl3.
Growth experiments. Strains 035E and 035E-CopB2 were grown overnight in
BHI broth with aeration. A 100-ml portion of this overnight culture was inocu-
lated into 10 ml of prewarmed BHI-DF30 in a 500-ml sidearm flask, and cell
densities were adjusted to a reading of 35 Klett units with a Klett colorimeter
(Klett Manufacturing Co., New York, N.Y.). Cultures were then allowed to grow
to late logarithmic phase, yielding a reading of 200 Klett units. This culture was
diluted to 1025 in prewarmed BHI broth, yielding a suspension containing 104
CFU/ml. Portions (100 ml) of the diluted suspension were inoculated into 1.9 ml
of BHI, BHI-DF30, or BHI-DF30 together with a specific iron source in plastic
culture tubes (17 by 100 mm). Cultures were then allowed to grow at 378C in a
gyratory water bath shaker (200 rpm), and 100-ml samples and appropriate
dilutions thereof were plated onto prewarmed BHI plates at hourly intervals for
8 h. Individual colonies on the BHI agar plates were counted after overnight
incubation. All growth experiments were repeated twice for a total of three
experiments.
Binding assays with transferrin and lactoferrin. Human transferrin and lacto-
ferrin were conjugated to horseradish peroxidase (HRP) with an ActiZyme-HRP
kit (Zymed Laboratories, South San Francisco, Calif.). Cultures (10 ml of broth
in a 500-ml sidearm flask) of strains 035E and 035E-CopB2 were allowed to grow
to a reading of 200 Klett units in BHI or BHI-DF30 as described above. These
cells were harvested by centrifugation for 10 min at 8,0003 g, and each cell pellet
was suspended in 1 ml of phosphate-buffered saline, pH 7.4 (PBS). Portions (2
ml) were spotted onto Whatman no. 40 filter paper (Whatman, Inc., Clifton, N.J.)
and dried at 378C for 1 h. After blocking for 1 h with Tris-buffered saline, pH 7.4,
containing 0.5% (wt/vol) powdered milk, filter papers were exposed to HRP-
transferrin or HRP-lactoferrin (2 mg/ml). After 4 h of incubation at room tem-
perature, filters were washed three times with Tris-buffered saline and developed
with 4-chloro-1-naphthol and H2O2 in Tris-buffered saline. E. coli HB101 was
used as the negative control strain.
Characterization ofM. catarrhalis outer membrane proteins.Outer membrane
vesicles were prepared by the method described by Murphy and Loeb (34), with
M. catarrhalis cells grown overnight in BHI and BHI-DF30. Proteins present in
these outer membrane vesicles were resolved by sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis (SDS-PAGE) and detected either by staining with
Coomassie blue or by Western blot (immunoblot) analysis as described previ-
ously (23).
Monoclonal antibodies (MAbs). MAb 10F3 is a murine immunoglobulin G2a
antibody reactive with the CopB outer membrane protein ofM. catarrhalis 035E,
012E (23, 24), and ATCC 25240. This MAb was used in the form of hybridoma
culture supernatant fluid in Western blot analysis.
Disk feeding assays. After overnight growth on BHI agar plates, bacterial
colonies were suspended in PBS and cell densities were adjusted to a reading of
100 Klett units. This suspension was diluted 1:100 in BHI, and 100-ml portions
were spread onto BHI-DF30 plates (for M. catarrhalis) or BHI plates supple-
mented with NAD (10 mg/ml) (for H. influenzae). Sterile filter paper disks (4-mm
diameter) were placed on the agar surface and impregnated with 5 ml of the
following iron sources: human transferrin (10 mg/ml), human lactoferrin (10
mg/ml), human hemoglobin (1 mg/ml), hemoglobin:haptoglobin (0.5 mg/ml),
bovine hemin (2.5 mg/ml), heme:hemopexin (0.5 mg/ml), and ferric citrate (100
mM). After overnight incubation, the diameter of the zone of bacterial growth
around each disk was measured.
55Fe uptake assay.M. catarrhalis 035E and 035E-CopB2 were grown overnight
on BHI agar plates, suspended in CDM (46) to a final reading of 20 Klett units,
and grown with shaking at 378C in a 95% air–5% CO2 atmosphere to induce iron
starvation. These cells were harvested in the late logarithmic phase of growth,
and iron uptake assays were performed exactly as previously reported (8) with
the following modifications. Nitrocellulose filters were blocked prior to use with
30 ml of bovine serum albumin (10 mg/ml) in CDM. Assays were performed in
200-ml volumes in 96-well filtration plates (MAHV; Millipore, Bedford, Mass.) at
378C in a 95% air–5% CO2 atmosphere. The vacuum manifold was from the
Millipore Multiscreen Assay System. Potassium cyanide (KCN) was dissolved in
13 CDM. Fifteen percent iron-saturated transferrin was used at a final concen-
tration of 1.08 mM, 22% iron-saturated lactoferrin was used at 1.28 mM, and
ferric citrate was used at 25 mM. Membranes were air dried overnight, and the
Millipore punch kit was used to separate and collect individual filters for subse-
quent measurement of bound radioactivity. Data were expressed as counts per
minute per microgram of protein. Data were compiled from three individual
experiments performed in triplicate on separate days.
RESULTS
Homology of CopB with TonB-dependent outer membrane
proteins. Analysis of the amino acid sequence of CopB from
strain 035E (23) revealed that this M. catarrhalis outer mem-
brane protein shared significant homology with the family of
TonB-dependent outer membrane proteins. As displayed in
Fig. 1, all seven regions of homology, including the TonB box
(28) located near the N terminus, are well conserved in CopB.
The highest degree of homology was seen with the iron-regu-
lated FrpB protein of N. gonorrhoeae, which was recently de-
scribed as being homologous to TonB-dependent outer mem-
brane proteins (6, 39). As noted by Beucher and Sparling (6),
TABLE 1. Bacterial strains used in this study
Strain Description Source or reference
Moraxella catarrhalis
035E Wild-type isolate from middle ear fluid 23, 24
035E-CopB2 Isogenic copB mutant constructed by electroporating 035E with
a mutated copB gene containing a mini-Tn10kan transposon
insertion
24
012E Wild-type isolate from middle ear fluid 24
ATCC 25240 Wild-type isolate American Type Culture Collection
Neisseria gonorrhoeae
FA19 Wild-type isolate 32
FA6775 lbpA::Tn3(Cm); mutant unable to express lactoferrin-binding
protein A
G. Biswas and P. F. Sparling
FA6747 tbpA::mTn3(Cm); mutant unable to express transferrin-binding
protein 1
12
Haemophilus influenzae type b DL42 Wild-type isolate 11
Escherichia coli HB101 Cloning host strain 42
FIG. 1. Peptide alignments between TonB-dependent outer membrane pro-
teins of other organisms and CopB. The other TonB-dependent proteins include
FrpB (N. gonorrhoeae iron-regulated outer membrane protein [6]), BtuB (E. coli
vitamin B12 receptor [21]), and Cir (E. coli colicin I receptor [35]). The numbers
indicate the residue position in the mature protein. The boxes indicates residues
that are identical in at least three of the four sequences.
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overall identity and similarity between CopB and this gono-
coccal outer membrane protein were 52 and 71%, respectively.
Similarly, CopB proved to be 49% identical to the FrpB pro-
tein of N. meningitidis (39).
Effect of iron on expression of CopB. The finding that CopB
was most similar to the iron-regulated FrpB protein of patho-
genic Neisseria species raised the possibility that CopB expres-
sion in M. catarrhalis might be controlled by iron availability.
Moreover, a recent report suggested that CopB expression was
increased under conditions of iron limitation (10). To investi-
gate this further, we grew three different wild-typeM. catarrha-
lis strains (035E, 012E, and ATCC 25240) as well as the iso-
genic copB mutant strain 035E-CopB2 in both iron-deficient
(i.e., BHI-DF30) and iron-replete (i.e., BHI) media and exam-
ined the outer membrane proteins present in these cells. Coo-
massie blue staining of outer membrane proteins resolved by
SDS-PAGE indicated that iron limitation in the growth me-
dium did not result in a dramatic increase in expression of
outer membrane proteins in two of the three wild-type M.
catarrhalis strains tested. In both strains 035E (Fig. 2, panel 1,
compare lanes A and B) and 012E (Fig. 2, panel 1, compare
lanes G and H), iron limitation resulted in a modest increase in
expression of a protein with an apparent molecular mass of
approximately 80 kDa. In strain 012E (Fig. 2, panel 1, lane H),
iron limitation also increased expression of one or more pro-
teins with an apparent molecular mass of 90 to 100 kDa. In
contrast, in strain ATCC 25240 (Fig. 2, panel 1, compare lanes
E and F), iron limitation resulted in greatly increased expres-
sion of several proteins with apparent molecular masses rang-
ing from 80 to 110 kDa. Interestingly, when the isogenic copB
mutant was subjected to the same iron limitation, increased
expression of several outer membrane proteins with apparent
molecular masses of 83 to 100 kDa was observed (Fig. 2, panel
1, compare lanes C and D).
Western blot analysis using MAb 10F3 to detect the CopB
protein revealed that CopB was the 80-kDa protein whose
expression was increased only slightly by iron limitation in
strains 035E (Fig. 2, panel 2, compare lanes A and B) and 012E
(Fig. 2, panel 2, compare lanes G and H). Similarly, one of the
several proteins whose expression was greatly increased by iron
limitation in strain ATCC 25240 was CopB (Fig. 2, panel 2,
compare lanes E and F). As expected, none of the proteins
expressed by the isogenic copB mutant reacted with the CopB-
specific MAb 10F3 (Fig. 2, panel 2, lanes C and D).
Utilization of iron sources by wild-type and mutant strains
of M. catarrhalis. The fact that increased expression of CopB
was correlated with iron limitation in the growth medium
prompted us to investigate whether CopB might be involved in
the utilization of iron by M. catarrhalis. As a first step, we
assessed the ability of M. catarrhalis strains to utilize various
iron sources for growth in vitro. These experiments involved
plating M. catarrhalis cells on agar-based media in which iron
availability had been restricted by the use of an iron chelator
(i.e., Desferal); filter paper disks impregnated with various iron
sources were then placed on the surface of the agar, and the
resultant growth zones around the disks were recorded.
All three wild-type M. catarrhalis strains tested in this study
could utilize ferric citrate, heme, transferrin, and lactoferrin as
iron sources (Fig. 3 and data not shown). These same strains
did not grow detectably around disks containing hemoglobin,
heme:hemopexin, and hemoglobin:haptoglobin. Control ex-
periments involving the wild-type H. influenzae type b strain
DL42 indicated that sufficient, utilizable quantities of these
protein-bound forms of heme were present in these disks (data
not shown). Both the wild-type parent strain 035E and its
isogenic copB mutant grew to the same extent when supplied
with ferric citrate or heme. In contrast, when either transferrin
or lactoferrin was provided as the sole source of iron for
growth, the copB mutant did not form a visible zone of growth
around disks containing either of these iron-containing pro-
teins (Fig. 3). Identical results were obtained when a second,
independently constructed copB mutant derived from strain
012E (24) was tested in this same system (data not shown).
Growth of M. catarrhalis 035E and 035E-CopB2 in broth
under iron-restricted conditions. To investigate further the
apparent difference between the wild-type strain 035E and the
isogenic copB mutant in their utilization of iron bound to
transferrin and lactoferrin, we compared the rates of growth of
these two strains in a broth-based medium. These two strains
were inoculated into BHI-DF30 containing ferric citrate, trans-
FIG. 2. Expression of outer membrane proteins by wild-type and mutant
strains of M. catarrhalis grown under iron-replete and iron-limited conditions.
Cells of the wild-type strain 035E (lanes A and B), the copB mutant strain
035E-CopB2 (lanes C and D), the wild-type strain ATCC 25240 (lanes E and F),
and the wild-type strain 012E (lanes G and H) were grown in BHI broth (lanes
A, C, E, and G) or in BHI broth containing 30 mM Desferal (lanes B, D, F, and
H). Proteins present in outer membrane vesicles extracted from these cells were
resolved by SDS-PAGE and stained with Coomassie blue (panel 1) or were
transferred to nitrocellulose and probed in Western blot analysis with the CopB-
specific MAb 10F3 (panel 2). Size markers (in kilodaltons) are present on the left
side of this figure. The arrows indicate the position of the CopB protein.
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ferrin, or lactoferrin as the iron source, and the extent of
growth was measured by viability determinations.
Both the wild-type and mutant strains grew at the same rate
in BHI broth (Fig. 4A and B, closed and open circles, respec-
tively). The addition of the iron chelator Desferal at a final
concentration of 30 mM effectively stopped growth of both the
wild-type and mutant strains (Fig. 4A and B, closed and open
squares, respectively). Addition of 25 mM ferric citrate over-
came completely the growth-inhibiting effect of the Desferal
(Fig. 4A and B, closed and open triangles, respectively). Ad-
dition of a lower concentration (5 mM) of ferric citrate allowed
slow growth of both the wild-type and mutant strains at nearly
equivalent rates in the presence of Desferal (Fig. 4A and B,
closed and open inverted triangles, respectively). These results
indicate that lack of CopB expression did not affect signifi-
cantly the ability of M. catarrhalis to obtain iron from ferric
citrate.
When either transferrin or lactoferrin was supplied to the
wild-type strain in the presence of 30 mM Desferal (Fig. 5,
closed triangles), this strain grew as rapidly and to the same
extent as it did in BHI broth alone (Fig. 5, closed circles). As
expected, the copBmutant (Fig. 5, open circles) grew as well as
the wild-type strain (Fig. 5, closed circles) in BHI broth; nei-
ther strain grew in BHI containing 30 mM Desferal (Fig. 5,
closed and open squares). When transferrin was the sole iron
source available to the copB mutant (Fig. 5A, open triangles),
this mutant strain did not grow and the number of viable
organisms decreased to a level beneath that of the starting
inoculum. Similarly, when the copB mutant was supplied with
lactoferrin as the iron source (Fig. 5B, open triangles), it did
not grow as rapidly as did the wild-type parent strain (Fig. 5B,
closed triangles), although the number of viable organisms did
not decrease with time (as was the case with transferrin).
Binding of transferrin and lactoferrin by wild-type and mu-
tant M. catarrhalis cells. The broth-based growth experiments
described above confirmed that the isogenic copB mutant was
less able than its wild-type parent strain to utilize both trans-
ferrin and lactoferrin as sources of iron. To determine whether
the decreased utilization of these iron sources was the result of
a significant diminution in the ability of the copB mutant to
bind these two proteins, a dot blot assay was used to measure
binding of both of these iron carrier proteins to M. catarrhalis
cells. The wild-type and mutant strains were grown in both
BHI and BHI-DF30 and tested for their ability to bind HRP-
conjugated forms of transferrin and lactoferrin (Fig. 6). There
was no apparent difference in the relative abilities of the wild-
type strain (Fig. 6, column A) and mutant strain (Fig. 6, col-
umn B) to bind transferrin, regardless of whether the cells were
FIG. 3. Utilization of iron sources by wild-type and mutant M. catarrhalis
strains in a disk feeding assay. The wild-type 035E strain (column A) and its
isogenic copB mutant strain 035E-CopB2 (column B) were plated on BHI
medium containing 30 mM Desferal, and then sterile filter paper disks were
pressed into the agar surface and spotted with the following iron sources: trans-
ferrin (Tf), lactoferrin (Lf), ferric citrate, PBS (negative control), hemin (H),
heme:hemopexin (HHx), hemoglobin (Hb), and hemoglobin:haptoglobin (HbHp).
FIG. 4. Growth of wild-type and mutant M. catarrhalis strains in iron-replete
and iron-limited broth supplemented with varying levels of ferric citrate. The
wild-type strain 035E (A) and the isogenic copB mutant 035E-CopB2 (B) were
inoculated into BHI broth (circles) and into BHI broth containing 30 mM Des-
feral alone (squares) or Desferal and either 5 mM (inverted triangles) or 25 mM
(triangles) ferric citrate. Growth was monitored over time by plating samples of
the cultures onto BHI agar plates.
FIG. 5. Growth of wild-type and mutant M. catarrhalis strains in iron-replete
or iron-limited broth supplemented with either transferrin or lactoferrin. (A)
The wild-type strain 035E (closed symbols) and the isogenic copB mutant (open
symbols) were inoculated into BHI broth alone (circles), BHI containing 30 mM
Desferal (squares), and BHI containing 30 mM Desferal and 10 mM transferrin
(triangles). (B) The same experiment was repeated except that 2.5 mM lactofer-
rin was substituted for transferrin. Growth was monitored as described in the
legend for Fig. 4.
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grown under iron-limited (BHI-DF30) or iron-replete (BHI)
conditions. When tested for lactoferrin binding, the copB mu-
tant (Fig. 6, column B) appeared to bind slightly less lactofer-
rin than did the wild-type parent strain (Fig. 6, column A). This
difference, though slight, was highly reproducible. Testing of
serial twofold dilutions of these cell suspensions in this dot blot
assay did not reveal any differences in transferrin-binding abil-
ity between the wild-type and mutant strains and confirmed
that the mutant bound slightly less lactoferrin than did the
wild-type strain (data not shown).
The fact that iron limitation did not result in an appreciable
increase in the binding of either lactoferrin or transferrin by
the wild-typeM. catarrhalis strain 035E correlated with the very
modest increase in expression of strain 035E outer membrane
proteins in response to iron limitation (Fig. 2, panel 1, lanes A
and B). This observation also confirms the findings of Schry-
vers and Lee (44), who demonstrated that, in comparison with
neisserial species, iron starvation resulted in only a moderate
increase in the binding of transferrin and lactoferrin by a wild-
type M. catarrhalis strain.
Uptake of 55Fe by wild-type and mutant M. catarrhalis
strains. A well-described iron uptake assay system (8, 16) was
used to determine whether the copB mutant differed from its
parent strain in its ability to take up iron from transferrin,
lactoferrin, and ferric citrate. Controls included the use of a
wild-type strain of N. gonorrhoeae (FA19) as well as a N. gonor-
rhoeae tbpA mutant (strain FA6747) (12) and a N. gonorrhoeae
lbp mutant (strain FA6775). Both the wild-type M. catarrhalis
strain and the wild-type N. gonorrhoeae strain took up 55Fe
from all three test compounds at equivalent rates (data not
shown). As expected, the N. gonorrhoeae tbpA mutant did not
take up iron from transferrin (Fig. 7C) and the N. gonorrhoeae
lbpA mutant did not take up iron from lactoferrin (Fig. 7B).
Iron acquisition by the M. catarrhalis copB mutant (Fig. 7E)
from transferrin and lactoferrin was substantially reduced rel-
ative to the wild-type parent strain (Fig. 7D). In contrast,
uptake of radiolabeled iron from ferric citrate by the copB mu-
tant (Fig. 7E) proceeded almost as rapidly as it did in the wild-
type parent strain (Fig. 7D).
DISCUSSION
TonB-dependent outer membrane proteins, the proper func-
tioning of which depends on the presence of a functional TonB
protein, bind various ligands (e.g., iron-siderophore complexes,
vitamin B12, heme) for subsequent transport into the gram-
negative bacterial cell (5, 19, 25, 26, 41). The TonB protein
itself spans the periplasm and is thought to be necessary for
energy transduction from the cytoplasmic membrane to ener-
gy-requiring outer membrane processes (12, 26, 41). These
TonB-dependent outer membrane proteins have seven regions
of homology, as defined by Lundrigan and Kadner (28), in-
cluding the TonB box located near the N terminus, which has
been implicated in direct interaction between TonB and these
outer membrane proteins (5, 9, 22, 43).
Close inspection of the amino acid sequence of CopB re-
vealed that it possesses not only this TonB box near the N
terminus but also the other six regions of homology. This
similarity was missed because of a database searching error in
a previous study (23). The last region of homology between
these TonB-dependent proteins and CopB is at the C-terminal
end of the molecule, where an amphipathic motif terminates
with an aromatic amino acid residue. This is characteristic of
virtually all outer membrane proteins and has been suggested
to be essential for outer membrane localization (45).
CopB is expressed in abundance when M. catarrhalis is
grown in complex media (e.g., BHI broth) (23, 34). Therefore,
the finding that CopB is homologous to TonB-dependent outer
membrane proteins was somewhat surprising inasmuch as most
previously described TonB-dependent proteins are not consti-
tutively expressed in other bacteria but are instead produced
in response to environmental conditions (e.g., iron starvation,
heme limitation, etc.). However, a recent report raised the
possibility that CopB expression could be regulated to some
extent by the availability of iron (10). The results of the present
study confirmed those of this previous report (10) and also
revealed considerable, strain-dependent variation in the level
of expression of CopB in response to iron limitation (Fig. 2).
Interestingly, CopB proved to be most similar (49 to 52%
identity) to the iron-regulated FrpB protein expressed by
pathogenic Neisseria species (6, 39). This finding, together with
the ability of iron availability to affect CopB expression (Fig.
2), raised the possibility that CopB might be involved in iron
utilization by M. catarrhalis. We first tested several wild-type
FIG. 7. Uptake of 55Fe from 55Fe-transferrin, 55Fe-lactoferrin, and 55Fe-
citrate by wild-type and mutant strains of bothM. catarrhalis and N. gonorrhoeae.
Uptake of 55Fe from ferric citrate (black columns), transferrin (hatched col-
umns), and lactoferrin (stippled columns) was measured as described in Mate-
rials and Methods. (A) Wild-type N. gonorrhoeae strain FA19; (B) N. gonor-
rhoeae lbpA mutant strain FA6775; (C) N. gonorrhoeae tbpA mutant strain
FA6747; (D) wild-typeM. catarrhalis strain 035E; (E)M. catarrhalis copBmutant
strain 035E-CopB2. 55Fe uptake by the wild-type parent strains was set at 100%
for comparison with the mutants. Standard deviations are indicated by error bars.
FIG. 6. Binding of transferrin and lactoferrin by wild-type and mutant strains
of M. catarrhalis. Cells of the wild-type strain 035E (column A) and the copB
mutant strain 035E-CopB2 (column B) were grown in BHI or in BHI containing
30 mMDesferal (BHI-DF30), harvested by centrifugation, and spotted onto filter
paper for incubation with HRP-coupled human transferrin (HRP-Tf) and lacto-
ferrin (HRP-Lf). E. coli HB101 grown on Luria-Bertani agar (column C) was
included as a negative control.
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M. catarrhalis isolates for their ability to utilize ferric citrate,
heme, hemoglobin, hemoglobin:haptoglobin, heme:hemopexin,
transferrin, and lactoferrin as sources of iron. All wild-type
isolates tested could use only iron citrate, heme, lactoferrin,
and transferrin for growth. By both disk feeding experiments
(Fig. 3) and broth-based growth determinations (Fig. 4 and 5),
it was found that an isogenic copB mutant was markedly im-
paired in its ability to utilize lactoferrin and transferrin but not
iron citrate.
Binding of lactoferrin and transferrin by the wild-type strains
and that by copB mutant strains were essentially equivalent
(Fig. 6), indicating that the copB mutation did not affect bind-
ing of these iron sources. This finding eliminated the possibility
that CopB is a homolog of either the Tbp1 or Lbp receptor
described elsewhere for pathogenic Neisseria species (7, 12, 27,
38). While the molecular mass of CopB is similar to that of
Tbp2, the latter has been shown to be a lipoprotein with no
similarity to TonB-dependent outer membrane proteins (2,
27).
Radiolabeled iron uptake studies revealed that the copB
mutant was impaired in its uptake of 55Fe from both lactoferrin
and transferrin, but not from ferric citrate (Fig. 7). The fact
that lack of CopB expression adversely affects but does not
eliminate the uptake of iron from both transferrin and lacto-
ferrin indicates that this outer membrane protein may facilitate
the extraction of iron from both of these carrier proteins.
Similarly, CopB may somehow stimulate the transport of trans-
ferrin- or lactoferrin-derived iron across the outer membrane.
Alternatively, the fact that utilization and uptake of both lacto-
ferrin-bound and transferrin-bound iron were affected to ap-
proximately the same extent in the copB mutant (Fig. 7) raised
the possibility that the effect of the copB mutation on these
processes might be indirect and caused by a concomitant
change in outer membrane architecture that affects the ability
of the M. catarrhalis lactoferrin- and transferrin-binding pro-
teins (44, 47) to extract iron from their respective ligands.
With regard to the latter possibility, a similar situation has
been reported with the iron-regulated FrpB protein (which is
52% identical to CopB) of N. gonorrhoeae, in which a frpB
mutation affected the uptake of iron from heme in a nonspe-
cific manner (6). An isogenic frpB mutant of N. gonorrhoeae
was able to use transferrin, lactoferrin, ferric citrate, hemoglo-
bin, and hemoglobin-haptoglobin complexes as iron sources
but was reduced by 60% in its ability to use heme-bound iron
compared with the wild-type parent strain. This effect of the
frpB mutation appeared to be nonspecific, however, as heme-
bound iron uptake by isogenic gonococcal mutants lacking
Tbp1, Tbp2, or Lbp was similarly affected (6). It has also been
reported that an isogenic meningococcal frpB mutant was un-
affected in its ability to use iron bound to transferrin or lacto-
ferrin (39).
It is of interest that the phenotype of the copB mutant, with
regard to the utilization of iron bound to transferrin and lacto-
ferrin, resembles that of one type of gonococcal iron uptake
mutant described several years ago (17). The pleiotropic tlu
mutants of N. gonorrhoeae were markedly impaired in their
ability to use iron from transferrin and lactoferrin, while iron
utilization from ferric citrate, heme, and hemoglobin was un-
affected (17). These tlu mutants were obtained by streptoni-
grin-based enrichment after chemical mutagenesis, and the
affected genetic locus was found not to be linked with either
transferrin or lactoferrin utilization loci (36).
It must be noted that CopB has been shown to bind anti-
bodies that enhance pulmonary clearance of M. catarrhalis
(23). In this regard, CopB is again similar to the FrpB protein
of the meningococcus, which has also been shown to be a
target for biologically active antibodies (37, 39). In addition,
lack of CopB expression affects the resistance of M. catarrhalis
to killing by normal human serum and the ability of this or-
ganism to resist clearance from the lungs of mice (24). While it
is very likely that the latter in vivo survival phenotype is directly
related to the serum sensitivity issue, when taken together with
the results of the present study, it is clear that a copB mutation
exerts significant pleiotropic effects on M. catarrhalis. If CopB
expression is truly essential for survival of this pathogen in
vivo, this would bode well for further consideration of CopB as
a potential vaccine candidate.
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